Search

Breast cancer screening has long been a cornerstone of women's healthcare. With 1 in 8 women diagnosed with breast cancer in their lifetime1, the United States Preventive Services Task Force (USPSTF) has developed screening recommendations to help detect early-stage cancer. Notably in 2023, the USPSTF revised the recommended age for biennial mammogram screenings for women with average risk to start at age 40 instead of 502, estimated to result in 19% more lives being saved3 by starting screening earlier. While initiating screening at an earlier age offers advantages to a wide demographic, concerns about the potential of over-screening prompted research into the feasibility of identifying women with lower breast cancer risk who could safely delay mammograms. While guidelines address high-risk individuals, a notable gap exists in providing recommendations tailored to those at lower risk. To gain insight into a patient's risk level, physicians are able to utilize genetic testing to understand an individual's genetic makeup, providing precise insights into their predisposition to various health conditions, including breast cancer. Armed with this genetic information, healthcare providers could craft tailored screening strategies that align with an individual’s specific risk profile. This genetic risk-based approach underscores the value of genetics in individualizing the onset of screening to help avoid over-screening and its associated costs. Surprisingly, genetic information is not currently being widely utilized to identify women at risk of breast cancer or other diseases in clinical practice, despite its potential to make a significant positive impact for patients. A recent retrospective analysis of 25,591 women from the Healthy Nevada Project4 sheds light on the potential benefits of this genetic risk-based approach. The study classified 2,338 (9.1%) of these women as having a low genetic risk for breast cancer. What's remarkable is that these women exhibited a significantly lower and later onset of breast cancer compared to their average or high-risk counterparts. This finding suggests that it might be safe for low-risk women to delay mammogram screening by 5 to 10 years without compromising their health.

Read More About Optimizing Mammogram Screenings: A Genetic Approach to a Personalized Screening Schedule

Cancer is challenging, but no one has to go through it alone. Patients and their loved ones can navigate the journey towards healing and recovery with the proper support and resources from Renown Health.  When faced with a cancer diagnosis, access to reliable and comprehensive cancer resources is key. These resources provide vital information, support, and guidance for patients, caregivers and loved ones throughout cancer treatment and recovery. Cancer Resources Breast Cancer Newly Diagnosed Orientation Class  Cancer Support Groups  Caregiver Support  General Cancer Support Group  Lymphedema & Physical Therapy  Men’s Prostate Cancer Support Group  Newly Diagnosed Breast Cancer Workshop  Smoking Cessation  Spiritual Center Activities & Programs  Sterling Silver 55+ Club Facebook Group  At Renown and in collaboration with community partnerships, we offer a variety of resources and specialty care programs focused on improving the quality of life after cancer including:  Cancer support groups play a crucial role in providing emotional, psychological, and practical assistance to those affected by cancer   These groups often consist of individuals who have been through similar experiences and can offer guidance, empathy, and understanding.   They provide a safe space for individuals to share their feelings, concerns, and experiences with others who truly understand what they are going through.

Read More About Navigating Renowns Cancer Care Resources Your Essential Guide